Zhende Medical Co., Ltd. (SHA:603301)
China · Delayed Price · Currency is CNY 91.00
+1.74 (1.95%)
Jul 31, 2026, 3:00 PM CST
Zhende Medical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 662.47 | 825.31 | 596.16 | 1,052 | 2,075 | 1,358 |
Trading Asset Securities | 406.14 | 283.32 | 232.23 | 155.62 | 99.67 | 5.22 |
Cash & Short-Term Investments | 1,069 | 1,109 | 828.39 | 1,207 | 2,175 | 1,364 |
Cash Growth | -12.09% | 33.83% | -31.39% | -44.48% | 59.50% | -41.00% |
Accounts Receivable | 632.18 | 728.76 | 764.06 | 550.51 | 793.96 | 694.52 |
Other Receivables | 69.73 | 44.81 | 148.69 | 45.86 | 34.08 | 38.5 |
Receivables | 701.9 | 773.58 | 912.74 | 596.37 | 828.04 | 733.02 |
Inventory | 831.32 | 754.13 | 770.72 | 800.81 | 929.59 | 833.5 |
Other Current Assets | 220.62 | 222.71 | 137.97 | 115.22 | 201.58 | 265.55 |
Total Current Assets | 2,822 | 2,859 | 2,650 | 2,720 | 4,134 | 3,196 |
Property, Plant & Equipment | 3,528 | 3,506 | 3,158 | 2,812 | 2,528 | 2,178 |
Long-Term Investments | 118.25 | 118.46 | 122.29 | 195.07 | 137.81 | 84.83 |
Goodwill | 1,029 | 1,037 | 788.78 | 787.83 | 474.49 | 398.52 |
Other Intangible Assets | 712.69 | 722.68 | 710.12 | 607.1 | 564.46 | 444.82 |
Long-Term Deferred Tax Assets | 62.4 | 65.71 | 65.25 | 79.5 | 53.4 | 56.03 |
Long-Term Deferred Charges | 20.24 | 20.03 | 10.45 | 2.29 | 3.3 | 3.92 |
Other Long-Term Assets | 71.66 | 71.93 | 71.98 | 62.78 | - | 60.35 |
Total Assets | 8,365 | 8,401 | 7,577 | 7,267 | 7,896 | 6,422 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 447.45 | 435.71 | 399.62 | 325.25 | 646.77 | 576.83 |
Accrued Expenses | 98.81 | 189.74 | 231.63 | 180.09 | 320.84 | 179.02 |
Short-Term Debt | 766.69 | 784.79 | 300.19 | 281.97 | 165.55 | 660.73 |
Current Portion of Long-Term Debt | 108.28 | 100.31 | 0.35 | 110.11 | 12.01 | - |
Current Portion of Leases | - | 5.23 | 3 | 5.44 | 3.12 | 9.75 |
Current Income Taxes Payable | 29.35 | 11.1 | 33.89 | 10 | 59.03 | 13.26 |
Current Unearned Revenue | 26.49 | 21.6 | 26.21 | 44.88 | 144.39 | 47.84 |
Other Current Liabilities | 239.76 | 259.68 | 165.15 | 214.56 | 167.02 | 115.18 |
Total Current Liabilities | 1,717 | 1,808 | 1,160 | 1,172 | 1,519 | 1,603 |
Long-Term Debt | 381.15 | 383.1 | 283.11 | 200.17 | 388.36 | 145.16 |
Long-Term Leases | 31.52 | 8.8 | 1.52 | 39.23 | 36.81 | 32.73 |
Long-Term Unearned Revenue | 215.85 | 215.24 | 218.02 | 231.98 | 176 | 173.9 |
Long-Term Deferred Tax Liabilities | 21.48 | 23.34 | 17.78 | 18.64 | 20.05 | 27.68 |
Total Liabilities | 2,367 | 2,439 | 1,680 | 1,662 | 2,140 | 1,982 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 265.84 | 265.84 | 266.45 | 266.45 | 266.45 | 227.2 |
Additional Paid-In Capital | 1,772 | 1,772 | 1,787 | 1,787 | 1,782 | 895.61 |
Retained Earnings | 3,753 | 3,698 | 3,602 | 3,351 | 3,552 | 3,009 |
Treasury Stock | -46.54 | -46.54 | -21.49 | -21.49 | -36.56 | -52.5 |
Comprehensive Income & Other | -19.36 | -3.14 | 8.95 | -17.71 | -23.61 | -12.42 |
Total Common Equity | 5,725 | 5,687 | 5,643 | 5,366 | 5,540 | 4,067 |
Minority Interest | 272.98 | 275.53 | 253.15 | 238.8 | 215.32 | 372.86 |
Shareholders' Equity | 5,998 | 5,962 | 5,896 | 5,604 | 5,756 | 4,440 |
Total Liabilities & Equity | 8,365 | 8,401 | 7,577 | 7,267 | 7,896 | 6,422 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,288 | 1,282 | 588.17 | 636.92 | 605.85 | 848.36 |
Net Cash (Debt) | -219.04 | -173.59 | 240.22 | 570.5 | 1,569 | 515.16 |
Net Cash Growth | - | - | -57.89% | -63.64% | 204.55% | -72.27% |
Net Cash Per Share | -0.83 | -0.66 | 0.90 | 2.13 | 6.62 | 2.27 |
Filing Date Shares Outstanding | 272.24 | 251.76 | 266.32 | 266.32 | 271.76 | 225.1 |
Total Common Shares Outstanding | 272.24 | 251.76 | 266.32 | 266.32 | 271.76 | 225.1 |
Working Capital | 1,106 | 1,051 | 1,490 | 1,548 | 2,615 | 1,593 |
Book Value Per Share | 21.03 | 22.59 | 21.19 | 20.15 | 20.39 | 18.07 |
Tangible Book Value | 3,983 | 3,927 | 4,144 | 3,971 | 4,502 | 3,223 |
Tangible Book Value Per Share | 14.63 | 15.60 | 15.56 | 14.91 | 16.56 | 14.32 |
Land | - | 20.5 | 18.39 | 21.99 | 1,386 | - |
Buildings | - | 2,343 | 1,807 | 1,658 | - | 1,068 |
Machinery | - | 1,780 | 1,630 | 1,453 | 1,175 | 1,084 |
Construction In Progress | - | 468.59 | 562.33 | 388.39 | 513.97 | 514.07 |